drugset / Trial / NCT05975788

Effect of Staphylococcus and Neisseria Tablets on Clinical Outcome Among Patients With Chronic Obstructive Pulmonary Disease

NCT05975788 ↗

Phase 4 Unknown 750 enrolled Peking University Third Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multi-center, prospective study. This study aims to investigate the incidence of acute exacerbation within 12 months, as well as the safety of Staphylococcus and Neisseria Tablets on patients with chronic obstructive pulmonary disease (COPD). In addition, this study investigates the improvement of hospitalization, improvement of pulmonary function, improvement of symptoms, and the use of anti-Infective drugs among COPD patients.

Timeline

Start
2023-11
Primary completion
2025-02
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Staphylococcus and Neisseria Tablets Unknown 0.3 mg —